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A B S T R A C T
Bioactivities of bulk ﬁsh protein hydrolysates (FPH) from defatted salmon backbones obtained with eight
different commercial enzymes and their combinations were tested. All FPH showed antioxidative activity
in vitro. DPPH scavenging activity increased, while iron chelating ability decreased with increasing time
of hydrolysis. All FPH showed ACE inhibiting effect which depended on type of enzyme and increased
with time of hydrolysis. The highest effect was found for FPH produced with Trypsin. Bromelain + Papain
hydrolysates reduced the uptake of radiolabelled glucose into CaCo-2 cells, a model of human
enterocytes, indicating a potential antidiabetic effect of FPH. FPH obtained by Trypsin, Bromelain + Papain
and Protamex showed the highest ACE inhibitory, cellular glucose transporter (GLUT/SGLT) inhibitory
and in vitro antioxidative activities, respectively. Correlation was observed between the measured
bioactivities, degree of hydrolysis and molecular weight proﬁles, supporting prolonged hydrolysis to
obtain high bioactivities.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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One third of Norwegian farmed salmon (370 600 ton from total
1 370 500 ton) was considered as rest raw materials in 2015.
Viscera and trimmings accounted for about 40% of the rest raw
materials, while heads and backbones made up about 8% each [1].
Proﬁtable utilization of ﬁsh rest raw materials is an important topic
for both research and ﬁsh industry. Protein hydrolysates rich in
bioactive compounds represent promising ingredients for food and
industrial applications. Fish protein hydrolysates (FPH) have been
reported to exhibit good functional [2,3] and nutritional properties
[3,4]. In addition, the hydrolysates exhibit bioactive properties
such as antioxidative, antihypertensive, anti-thrombotic and
immunomodulatory activities [5]. Bioactive peptides can be
produced by endogenous enzymes or using commercial enzymes
[6]. In regard to a successful commercialization bulk production is
more viable, due to dramatically lowered costs compared to
fractionated puriﬁed alternatives.* Corresponding author.
E-mail address: rasa.slizyte@sintef.no (R. Slizyte).
http://dx.doi.org/10.1016/j.btre.2016.08.003
2215-017X/ã 2016 The Authors. Published by Elsevier B.V. This is an open access article unAntioxidative properties could be used to prolong shelf life of
supplemented products. Hydrolysates are reported to inhibit
radical formation by inhibiting the transition metal catalysed
production of free radicals from hydroperoxides [7]. Moreover,
through hydrogen donation, free radicals can be directly scavenged
by 3–20 amino acids peptides [8]. However, mechanism for
hydrolysates cannot be generalised as it can be dependent on
several factors like composition, conﬁguration of proteins, the
oxidation system (emulsions, other additives presence etc)
involved, therefore indicating the need to test the antioxidativity
of novel FPH.
Antihypertensive actions of protein hydrolysates are mainly
attributed to their inhibition of Angiotensin converting enzyme
(ACE), which is a key target for existing pharmaceuticals such as
PeptACE1, Vasotensin1 [9]. However, these come with side effects
and naturally derived ACE inhibitors are desirable to address these
problems. These novel ingredients could translate into substantial
economic beneﬁts through the reduction of morbidity and
mortality from cardiovascular diseases caused by chronic hyper-
tension [12].
Secondary dietary ingredients, such as ﬂavonoids [10] and
chromium dinicocysteinate [11] have been shown to limit glucoseder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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transporter proteins GLUT1, GLUT2 and SGLT1 [10]. Due to
potential structural similarities it is feasible to investigate such
functions of FPH. Subsequently developed nutraceuticals could be
utilized to remedy blood glucose spikes associated with high
glycaemic foods. A reduced glycaemic index will contribute to
regulated blood glucose levels in the prevention and treatment of
diabetes and cardiovascular diseases [12,13], addressing the
obesity and diabetes “epidemic’ and therefore huge commercial
and socio-economic potential.
The main aim of this work was to screen for bioactivities in bulk
hydrolysates obtained from defatted salmon backbones. The
antioxidative properties of FPH were studied to evaluate their
potential as natural preservatives or functional ingredients in food
products. In addition, the antihypertensive (ACE-inhibitory) and
antidiabetic (intestinal glucose transport inhibitory) effects were
studied to assess the hydrolysates suitability of the produced as
health promoting agents.
2. Materials and methods
2.1. Raw material
Fresh salmon backbones were obtained from a local ﬁsh market
(Trondheim, Norway) on the same day as the ﬁsh was hand ﬁlleted.
The backbones were kept on ice before processing. The backbones
were minced in a HOBART mincer (model AE 200) with holes of
10 mm (in order to follow most accurately the possible industrial
mincing process). The minced material was packed in plastic bags
(approx.1 kg per unit) and vacuum packed. This was performed in a
cold room at 10 C and completed in 1 h. The vacuum packed
minced raw material were placed into warm water bath for 20 min
in order to warm up the raw material to 40 C (to avoid a large
degree of denaturation), then kept at stable temperature for 5 min,
then material centrifuged at 2250  g for 15 min. Then oil fraction
was separated by pipetting and the mixture of stick water and
sediments (defatted material) were used for hydrolysis.
2.2. Chemicals
The chemicals and solvents used in this study were of analytical
or chromatography grade and were purchased from Sigma-Aldrich
Chemie GmbH (Steinheim, Germany), Merck KGaA (Darmstadt,
Germany) or Fluka Chemie (Buchs, Germany). The following
abbreviations for chemicals are used in the text: MES = 2-(N-
morpholino)ethanesulfonic acid, ferrozine = 3-(2-pyridyl)-5,6-bis
(4-phenyl-sulfonic acids)-1,2,4-triazine, DPPH = 2,2-Diphenyl-1-
picrylhydrazyl radical. For glucose uptake experiments, [3H]-
methyl-D-glucose (80.0 Ci/mmol) was purchased from Perki-
nElmer. Human intestinal tumor cells CaCo-2E were purchasedTable 1
Enzymes used for the production of salmon backbones hydrolysates.
Enzyme Manufacturer Source 
Corolase1 PP AB Enzymes GmbH Pig pancreas glands 
Corolase1 7089 AB Enzymes GmbH Bacillus subtilis 
Protamex1 Novozymes A/S Bacillus licheniformis, B
amyloliquefaciens
Papain 100TU/mg Enzybel Carica papaya 
Bromelain 400 GDU/g Enzybel Ananas comosus 
Protex 6L Genencor Bacillus licheniformis 
Seabzyme L 200 Speciality Enzymes &
Biotechnologies
Carica papaya 
Trypsin Sigma-Aldrich Bovine pancreas from American Type Culture Collection, ATCC. Chemicals were
purchased from Sigma and designated with the following
abbreviations: DMEM = Dulbecco’s Modiﬁed Eagle’s Medium,
FBS = Fetal Bovine Serum, HEPES = N-(2-Hydroxyethyl)pipera-
zine-N0-(2-ethanesulfonic acid), CHAPS = 3-[(3-Cholamidopropyl)
dimethylammonio]-1-propanesulfonate hydrate.
2.3. Enzymes
Based on a literature survey with focus on obtained bioactivities
(antihypertensivity, antioxidativity and other) [6,14] and our
earlier experience, eight different proteolytic enzymes were
selected for enzymatic hydrolysis (Table 1). Corolase1 PP and
Corolase1 7089 (both from AB Enzymes GmbH), Protamex1
(Novozymes A/S), Papain FG and Bromelain 400 GDU/g (both from
Enzybel), Trypsin (Sigma Aldrich), Protex 6L (Genecor) and
Seabzyme L 200 (Specialty Enzymes & Biotechnologies) were
received from the producer.
2.4. Enzymatic hydrolysis
The mixture of stick water and sediments after oil separation was
used as a raw material for hydrolysis. The hydrolysis was performed
in a 4L closed glass vessel placed in a water bath (52 C) and stirred
with a marine impeller (100–150 rpm) in order to ensure homoge-
neity of the mixture during the whole hydrolysis. Warm (approx.
50 C) distilled water (1:1 of raw material mass) was added. The
enzymatic hydrolysis was started when the temperature of the
mixture had reached 50 C by adding enzyme dosed at 0.1% (w/w of
raw material mixture). In the case of combination of enzymes, each
enzyme was added at 0.05% + 0.05% (w/w) of raw material mixture.
The hydrolysis proceeded for 120 min followed by enzyme
inactivation by microwave heating for 5 min at temperature
>90 C. The mixtures were cooled down to room temperature,
placed in 50 mL graduated centrifuge tubes (NUNCTM) and
centrifuged at 6500  g for 10 min. After centrifugation, the tubes
were put upright in a freezer (–80 C) and all fractions: oil, emulsion,
ﬁsh protein hydrolysate (FPH) and sediments were separated by
cutting the frozen content of the tubes. The FPH fractions were
freeze-dried. Two control hydrolyses were performed using Prota-
mex, which is a common industrially used enzyme, as follows:
Control 1 (C1): Hydrolysis with raw material without initial
separation of oil; Control 2 (C2): Hydrolysis of raw material after
initial separation of oil and without addition of water. All hydrolysis,
inactivation and separation steps were done as described above. In
order to investigate the changes during hydrolysis, representative
samples from each hydrolysis were taken at 0 (stick water, taken
before addition of commercial enzymes), 20, 40, 60 and 120 min of
hydrolysis.Main activities Abbreviation
Endopeptidase, amino- & carboxypeptidase C-PP
Metalloendopeptidase, subtilis neutral
proteinase
C-7089
acillus Serine endopeptidase,
metalloendopeptidase
Pr
Cysteine endoprotease, broad speciﬁcity P
Cysteine endoproteases, broad speciﬁcity Br
Alkaline serine endopeptidase P-6L
Endoprotease Sz
Serine endoprotease T
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Moisture content was determined gravimetrically after drying
for 24 h at 105 C until constant weight was achieved. Ash content
was determined according to AOAC [15]. Total nitrogen (N) was
determined by CHN-S/N elemental analyser 1106 (Costech Instru-
ments ECS 4010 CHNSO Analysator) and crude protein was
estimated by multiplying total N by a factor of 5.8 [16,17]. The
measurements were performed in four parallels. The Bligh and
Dyer [18] method was used for extraction of lipids. The analyses
were performed in duplicates.
2.6. Degree of hydrolysis
The degree of hydrolysis (DH) was evaluated as the proportion
(%) of a-amino nitrogen with respect to the total N in the sample
[19]. Analyses were performed in duplicate.
2.7. Molecular weight distribution
Molecular weight distribution of the hydrolysates was analyzed
using gel ﬁltration on a FPLC system. Hydrolysate powder (0.1 g)
was dissolved in acetate buffer (4 mL, 0.05 M, pH5). The sample
(100 mL) was separated on a SuperdexTM Peptide 10/300 GL
column, which separates peptides with a molecular weight range
from 7000 to 100 Da. The standards used were Cytochrome c (Mw
12400), Aprotinin (Mw 6500), Vit B12 (Mw 1355) and Hippuryl L
phenylalanine (Mw 326).
2.8. Determination of free amino acid content (HPLC)
The content of free amino acids in the FPH was determined
according to Osnes and Mohr [20]. Protein was precipitated in 2.5%
sulfosalicylic acid and the supernatant was diluted using doubly
distilled water. The samples were analysed using reversed phase
High Pressure Liquid Chromatography (HPLC) (SIL-9A Auto
Injector, LC-9A Liquid Chromatograph, RF-530 Fluorescence HPLC
Monitor, Shimazdu).
2.9. Metal chelating ability
Ability to chelate Fe2+ was determined as described by
Klompong and others [21] with some modiﬁcations. One millilitre
of protein solution (10 mg/mL) was mixed with 3.7 mL of water.
The mixture was reacted with 0.1 mL of 2 mM FeCl2 and incubated
at room temperature for 20 min with 0.2 mL of 5 mM 3-(2-pyridyl)-
5,6-bis(4-phenyl-sulfonic acids)-1,2,4-triazine (ferrozine). The
absorbance was read at 562 nm. The control was prepared in
the same manner except that water was used instead of sample. In
order to eliminate the absorbance of protein itself, the absorbance
of the sample, prepared in the same manner except that water was
used instead of the iron solution, was read. Chelating activity (CA,
%) was calculated as follows:
CA ¼ 1  A562sample  A562protein
A562control
 
 100
2.10. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
activity
DPPH radical scavenging was determined as described by
Thiansilakul and others [22] with a slight modiﬁcation. Proteins
were dissolved in water at 0.25% concentration. 1.5 mL of protein
solutions were mixed with 1.5 mL of 0.15 mM DPPH in 96% ethanol
and allowed to stand at room temperature in the dark for 30 min.The absorbance was measured at 517 nm. In the blank distilled
water was used instead of the sample. For the control sample
ethanol was used instead of the DPPH ethanol solution. The radical
scavenging ability (RSA, %) was calculated as follows:
RSA ¼ Ablank  Asample þ Acontrol
 
=Acontrol
  100
2.11. Investigation of ACE-inhibiting activity
The ACE-inhibiting activity was investigated by a method based
on Vermeirssen and others. [23], as modiﬁed by Geirsdottir and
others [24] and Hansen [25]. The method is based on the reaction
between the enzyme ACE and the substrate FAPGG (N[-3(2-Furyl)
acryloyl]-Phe-Gly-Gly) to furylacryloylphenylalanine (FAP) and
glycylglycine (GG). This reaction can be inhibited by bioactive
peptides found in e.g. FPH. The following reagents were used
solution of angiotensin-converting enzyme (Sigma Aldrich), 0.2U/
mL (denoted ACE), substrate: 0.5 mM N[-3-(2-Furyl)acryloyl]-Phe-
Gly–Gly in 50 mM Tris-HCl buffer containing 300 mM NaCl at pH
7.5 (denoted FAPGG), inhibitor: different concentrations of FPH
(freeze dried powder) dissolved in 0.1 M NaCl. As standards,
different concentrations of Ala-Tyr (0.1, 0.75 and 1.5 mg/mL) and
Val-Trp (0.001, 0.01 and 0.1 mg/mL) were used. The ACE-inhibiting
activity of the standards was measured in the same way as
described for the hydrolysates. The ACE inhibiting activity (ACEI) of
the FPHs was calculated based on the following equation:
ACEI(%) = (1  Dsample/Dcontrol)  100
Dsample is the slope of the development of absorbance over time
for the reaction mixture containing the inhibitor FPH. Dcontrol is
the slope for the corresponding control sample containing distilled
water instead of inhibitor solution.
As the assays are performed with three to four different
inhibitor concentrations (each concentration was analysed in three
parallels), the concentration of the protein hydrolysate needed to
inhibit the ACE by 50% (IC50) was determined. The uncertainty was
calculated based on equations for error propagation (Gauss error
propagation law). Bromelain + Papain hydrolysates obtained after
0, 20, 40, 60 and 120 min hydrolysis, Protamex hydrolysates
without defatting and Trypsin hydrolysates on defatted raw
materials after 40, 60 and 120 min hydrolysis were analysed for
ACE inhibiting effect. Hydrolysates with all other enzymes were
used for ACE inhibiting effect test after 120 min hydrolysis.
2.12. Investigation of cellular glucose uptake inhibiting activity
The hydrolysates obtained from 60 min treatment of salmon
backbones with Protamex, Seabzyme, Protex 6L, Corolase 7089 and
Corolase PP, and from 0, 20, 60 and 120 min treatment with
Bromelain + Papain were investigated for their ability to inhibit
cellular glucose uptake. Human intestinal tumor cells were
cultured in a humidiﬁed incubator in an atmosphere of 5% CO2
 95% air (v/v) at 37 C. The cells were grown in DMEM (17.5 mM
glucose) supplemented with 10% heat-inactivated FBS, and
subcultured at conﬂuence by Trypsin treatment.
For glucose transport experiments, cells were seeded onto 96-
well plates and grown to conﬂuence. Cells were preincubated with
Krebs buffer (glucose 5 mM, HEPES 30 mM, NaCl 130 mM, KH2PO4
4 mM, MgSO4-7H2O 1 mM, CaCl2-2H2O 1 mM, pH 7.4) for 30 min at
37 C. Transport experiments were initiated by replacing the buffer
with Krebs buffer without glucose, containing [3H]-methyl-D-
glucose (0.125 mM) and FPH (4 mg/mL). Transport experiments
were continued for 15 min at 25 C and terminated with the
addition of ice-cold Krebs buffer. Cells were washed twice with ice-
cold Krebs buffer and lysed with 60 mL of NaOH (0.1 M)/CHAPS
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separate set of experiments where the transport buffer was
supplemented with 1, 4 or 8 mg/mL FPH. 45 mL aliquots of cell
lysates were added to 5 mL of scintillation cocktail and the [3H]-
methyl-D-glucose concentration was quantiﬁed by scintillation
counting. Protein content of the remaining cell lysates was
determined using DC Protein Assay Kit (Bio-Rad, USA). The uptake
of radiolabelled glucose into CaCo-2E cells was expressed as fmol
glucose and normalized to the protein content of the cell lysates.
Viability of the intestinal Caco-2E cells and validity of the assay was
demonstrated by linear uptake rates of radiolabelled glucose over
15 min in the absence of FPH. All data represent means of at least
two experimental sets in which the results were consistent. Each of
the experimental sets consisted of three parallel transport
experiments (n = 6).
2.13. Statistical analysis
Statistical analysis was carried out by general linear model
multivariate analysis using SPSS software (version 12.0.1, SPSS Inc.,
USA). Level of signiﬁcance was set at p < 0.05 and assessed by
Tukey’s test.
3. Results and discussion
3.1. Yield and composition of FPH
Efﬁciency of enzymatic hydrolysis was evaluated based on the
amount of dry material which ends up in ﬁsh protein hydrolysate
(FPH). Table 2 shows that the ﬁrst 20 min of hydrolysis led to the
most signiﬁcant increase in FPH yield. Trypsin (T) and Corolase PP
(C-PP) increased the yield by more than 100% during the ﬁrst
20 min of hydrolysis. Solubilisation by other enzymes was also the
most intensive during ﬁrst 20 min and gave 60–70% increase in FPH
yield. Further hydrolysis up to 120 min led to slower increase of
FPH yield. After 120 min hydrolysis the same tendency was
observed: Trypsin, Corolase PP and mixture of Bromelain + PapainTable 2
Yield of FPH as a function of hydrolysis time for all studied enzymes and enzyme mixture
from 100 g raw material. C-PP: Corolase PP, T: Trypsin, P-6L: Protex 6L, C-7089: Corolase 7
material without thermally separated oil before hydrolysis: control 1-C1, Pr-W: hydrol
Hydrolysis time, min C-PP T P-6L C-7
0 4.1  0.2 
20 9.4 8.3 7.1 6.7
40 9.5 10.0 7.5 7.8 
60 10.1 10.1 8.0 8.6
120 11.5 12.1 8.5 9.3
Table 3
Composition of FPH. Values are presented as average of the measurements (% of dry m
Water  0.0% Ash  0.1% 
Hydrolysis time 0 120 0 1
Enzyme
C-PP 10.6 6.6 11.9 6
T 7.8 3.1 11.5 6
P-6L 6.9 6.2 12.4 6
C-7089 10.6 4.2 11.9 5
BrP 7.8 3.8 11.5 6
Sz 6.9 8.9 12.4 6
Pr 8.6 3.6 10.8 6
Pr-T: C1 5.3 5.9 6.7 5
Pr-W: C2 8.6 4.4 10.8 6(BrP) yielded the highest amount of FPH 12.1, 11.5 and 11.6 g dry
FPH/100 g raw material respectively. Four other enzymes (Prota-
mex, Seabzyme, Protex 6L and Corolase 7089) gave similar yield of
dried FPH after 120 min hydrolysis. The three of these four last
enzymes (except Seabzyme) originate from microorganisms, while
the best yields were obtained from digestive or fruits enzymes.
Similar results were reported by Aspmo and others [26] where 1 h
hydrolysis of cod viscera with Papain yielded higher amounts of
hydrolysates compared to hydrolysis with Protamex and Neutrase.
Composition of hydrolysates obtained after 120 min hydrolysis
is presented in Table 3. The dried hydrolysates contained 83–86%
protein, 6.7–12.4% ash and 2.2–18.6% lipids. The initial separation
of oil from the raw material before hydrolysis was found to be
necessary with respect to the amount of lipids in FPH: Hydro-
lysates obtained from minced salmon backbones without initial
separation of oil (C1) contained signiﬁcantly more lipids (18.6%)
compared to all hydrolysates (2.2-6.2% lipids) obtained after
hydrolysis of defatted raw material.
3.2. Molecular weight distribution, degree of hydrolysis and free
amino acids
The molecular weight distribution of the FPH reﬂects the results
from FPH yield calculations. Already after 20 min of hydrolysis the
amount of large > 10000 Da components started to decrease
(Fig. 1A and B). The subsequent hydrolysis increased the amount
of smaller (200–500 Da) peptides, but changes were not signiﬁ-
cant.
Based on molecular weight distribution, FPH after 120 min of
hydrolysis can be divided into three groups (Fig. 1C). Hydrolysates
obtained with Trypsin and Corolase PP can be ascribed to the ﬁrst
group: these hydrolysates contained similar amount of peptides
with Mw > 2500 Da. Only these two hydrolysates had distinctive
peaks representing peptides with molecular weight approx. 1400–
1600 and 650–700 Da, containing 12 and 5 amino acids,
respectively. Additionally, the hydrolysates after Corolase PP
hydrolysis had high yield (Table 2) and degree of hydrolysiss as well as for control hydrolysis with Protamex. Values are presented as g dry FPH
089, BrP: Bromelain + Papain, Sz: Seabzyme, Pr: Protamex, Pr-T: Protamex with raw
ysis with Protamex without addition of water: control 2-C2. n.a.: not analysed.
089 BrP Sz Pr Pr-T
C1
Pr-W
C2
5.5 2.2
 7.1 6.6 7.1 n.a. 3.8
n.a 7.6 8.2 n.a. 4.3
 7.5 n.a. 8.6 n.a 4.7
 11.6 9.9 9.4 11.5 3.4
eterial) with standard deviation of the mean.
Lipids  0.0% Proteins  0.2%
20 0 120 0 120
.0 5.1 2.1 73.8 83.3
.1 2.2 1.7 79.0 85.8
.7 2.9 0.8 73.8 83.8
.9 5.1 1.3 73.8 83.4
.8 2.2 1.1 79.0 83.3
.7 2.9 1.6 73.8 82.9
.7 6.2 4.4 73.8 83.4
.7 18.6 9.7 73.8 78.0
.3 6.2 1.7 73.8 83.2
Fig. 1. Molecular weight distribution proﬁles of the hydrolysates obtained after different hydrolysis time: 20, 40, 60 and 120 min. Hydrolysis with: A) mixture of
Bromelain + Papain (BrP); B) Trypsin (T); C) hydrolysates after 120 min hydrolysis; D) Protamex (Pr) after 120 min hydrolysis. Pr-T 120 hydrolysates obtained without
thermal separation of oil, Pr-W 120: hydrolysates of defatted salmon backbones without addition of water, Pr 120: hydrolysates of defatted salmon backbones. Samples “0”
stick water sample before the addition of commercial enzymes.
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Table 4
Degree of hydrolysis of FPH obtained by use of different enzymes as a function of hydrolysis time, %, n.a.: not analysed. Values are presented as average of the measurements
with standard deviation.
Hydrolysis time, min C-PP T P-6L C-7089 BrP Sz Pr Pr-W Pr-T
0 13.4  0.5 8.4  0.1
20 17.9  0.5 14.2  1.8 14.5  0.2 14.3  0.1 13.4  0.1 13.0  0.0 15.3  0.3 15.0  0.1 n.a
120 22.1  0.4 18.1  0.2 18.2  1.4 18.3  0.2 16.8  0.1 17.1  1.5 20.9  0.5 21.8  0.7 22.6  0.2
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with the higher DH (Fig. 1C, Fig. 2). The second group covers
hydrolysates after 120 min hydrolysis produced with plant
enzymes Seabzyme and with a mixture of Bromelain + Papain.
Compared to the other samples, these hydrolysates had more
peptides consisting of 42–47 amino acids with molecular size
approx. 5500–6500 Da. These two hydrolysates had the lowest
degree of hydrolysis (Table 4). Both the DH and yield was slightly
higher for the Bromelain + Papain hydrolysate, which also had
higher content of free amino acids compared to Seabzyme
hydrolysates. Hydrolysates obtained by microbial enzymes (Protex
6L, Protamex and Corolase 7089) belong to the third group. These
hydrolysates also have similar DH. Unlike other samples in this
group, the Protamex hydrolysate gave a distinctive peak at approx.
140 Da, corresponding to free amino acids. Variation in the
hydrolysate molecular weight proﬁles can be explained by
differences in substrate speciﬁcity and activity of the studied
enzymes at the selected conditions. The size and terminal
sequences are important factors affecting peptide bioactivity.
Small tri- and dipeptides are less prone to gastrointestinal
hydrolysis and thus are expected to be more stable candidates
for exerting physiological effects in vivo [27].
Pre-treatment (thermal separation of oil) and different process
conditions (amount of added water) did not signiﬁcantly inﬂuence
the molecular size proﬁle of hydrolysates obtained by the use of
the same enzyme (Fig. 1D). However, the Protamex hydrolysates
produced without thermal pre-treatment (Pr-T) had slightly higher
DH than those obtained after pre-treatment (Pr, Pr-W) (Table 4).
Thermal pre-treatment of Pr and Pr-W samples may have led to
partial inactivation of endogenous enzymes, resulting in lower DH
than in Pr-T.
Amount of free amino acids varied from 24 to 170 mg/100 g dry
FPH and correlated with degree of hydrolysis (Table 4 and Fig. 2).
For some hydrolysates increase in degree of hydrolysis wasFig. 2. Correlation between degree of hydrolysis and amount of free amino acids iinﬂuenced by increase in the amount of free amino acids, while for
others production of short-chain peptides led to higher degree of
hydrolysis. Short-chain peptides have been associated with higher
bioactivity such as antioxidativity, positive effects for cardiovas-
cular systems [14,28], and may also be more efﬁciently absorbed
from the digestive system than free amino acids or intact proteins
[29]. Therefore, partial hydrolysis using endoproteases is more
desirable than the use of proteases giving a high release of amino
acids.
3.3. DPPH radical scavenging
All studied FPH showed antioxidative DPPH radical scavenging
ability. All (n = 5) zero samples (stick water before addition of
commercial enzymes) showed 50% DPPH scavenging effect.
Hydrolysis for 20 min led to increased DPPH scavenging effect by
10–25% compared to the DPPH activity of the proteins without
hydrolysis (Fig. 3). The highest DPPH scavenging ability was shown
in FPH obtained using a mixture of Bromelain + Papain (BrP) and
Trypsin (T). FPH with the lowest DPPH scavenging ability were
made using Seabzyme (Sz) and Protex 6L (P-6L).
By hydrolysing salmon backbones further for 120 min, DPPH
scavenging ability of FPH slightly increased for hydrolysates
obtained with Protamex (without thermal separation of oil before
hydrolysis: Pr-T), Corolase PP (C-PP), Seabzyme (Sz) and Protex 6L
(P-6L) (Fig. 3A). However, prolonging the time of hydrolysis (from
20 to 120 min) using Bromelain + Papain mixture (BrP), Trypsin (T),
Corolase 7089 (C-7089), and Protamex with and without water (Pr,
Pr-W) did not increase DPPH radical scavenging ability (Fig. 3B).
The FPH with the highest scavenging activity were obtained
after 120 min hydrolysis using Protamex (without separation of oil
before hydrolysis, Pr-T, 38  0.5% increase) and Corolase PP
(32  3% increase). These samples also showed the highest degree
of hydrolysis (Table 4). Hydrolysis of salmon backbones withn the dried FPH after 120 min hydrolysis using different commercial enzymes.
Fig. 3. Increase in DPPH scavenging ability of proteins from salmon backbones compared to DPPH activity of proteins before hydrolysis as effect of hydrolysis time. Samples:
Pr-T: hydrolysis with Protamex (without separation of oil before hydrolysis); C-PP: Coralase PP, Sz: Seabzyme, P-6L: Protex 6L, BrP: Bromelain + Papain mixture, T: Trypsin, C-
7089: Coralase 7089, Pr-W: Protamex without addition of water and Pr: Protamex.
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26% in comparison to unhydrolysed protein. However, degree of
hydrolysis for FPH produced by Protex 6L and Seabzyme were
measured 18.2% and 17.1%, respectively. The effect of both enzyme
type used for hydrolysis and degree of hydrolysis of the protein
hydrolysate was also obtained in other studies [30]. This shows
that degree of hydrolysis and size of produced peptides cannot
alone predict the DPPH scavenging ability.
3.4. Iron chelation
Iron chelating ability of the FPH varied from 54 to 87% (Fig. 4).
However, the hydrolysates were less effective chelators than casein
from milk, which chelated iron by 100% at the same concentration.
The water soluble fraction (stick water) obtained from salmon
backbones at time 0 showed an iron chelating ability of 80%.
Hydrolysis for 20 and 120 min slightly reduced the proteins ability
to chelate iron. FPH produced with mixture of Bromelain + Papain
(BrP) after 20 min of hydrolysis exhibited the best iron chelating
ability. These results indicate that larger peptides have better
ability to chelate iron and this property weakens when the peptide
size is reduced with hydrolysis time. This is opposite to the DPPH
scavenging ability that increased after 20 min of hydrolysis
compared to 0 time hydrolysis sample. During hydrolysis
formation of smaller peptides increased their ability to scavenge
radicals. However, metal chelating ability of proteins is also
dependent on the amino acid composition, sequence and protein
conﬁguration [7]. Slightly reduced metal chelating ability with
increased degree of hydrolysis was also observed by Thiansilakuland others [31] hydrolysing round scad muscle with Flavourzyme.
When hydrolysing salmon backbones, changes in the conformation
and structure of water soluble peptides or properties of other
components may have slightly reduced ability to chelate iron.
Indirect antioxidative activity tests are useful for evaluation and
screening of possible antioxidants, but it is also advisable to test
the antioxidants in the systems containing lipids. However, very
complex systems with transport limitations, containing other
additives affecting the oxidation kinetics, could mask the real
effect of the compound of interest on the oxidation. The conﬂicting
results from the DPPH radical scavenging and iron chelating ability
show that different protein properties are responsible for different
antioxidativity mechanisms.
3.5. ACE inhibition
3.5.1. Effect of enzymes used
All FPH produced using nine different enzyme combinations
with more than 20 min of hydrolysis showed potential ACE-
inhibiting activity in vitro. Among the studied enzymes, Trypsin
was the most efﬁcient enzyme for production of ACE-inhibiting
peptides after 120 min hydrolysis (Fig. 5). Inhibitory activity of the
hydrolysates showed an increase with hydrolysis time. Based on
their ACE-inhibiting activity after 120 min of hydrolysis, FPHs can
be divided into three groups. The ﬁrst group covers the Trypsin
hydrolysate, having similar IC50 value as the standards (Val-Trp
and Ala-Tyr) which have documented ACE-inhibiting activity effect
[32,33]. These samples had the best ACE-inhibiting activity with
IC50 values of 0.2–0.9 mg/mL (Fig. 5). Most of the hydrolysates fell
into the second group with IC50 values of 2.8–4.6 mg/mL.
Fig. 4. Ability to chelate iron as a function of hydrolysis time for proteins from salmon backbones. Sample: C-PP: Coralase PP, T: Trypsin, P-6L: Protex 6L, C-7089: Corolase
7089, BrP: Bromelain + Papain, Sz: Seabzyme, Pr: Protamex, Pr-T: Protamex without thermally separated oil before hydrolysis, Pr-W: hydrolysis of deffated salmon backbones
with Protamex without addition of water.
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and appears to be the least efﬁcient, displaying an IC50 value 2–
3 times larger than the hydrolysates in group 2.
The differences in IC50 values indicate that ACE-inhibiting
effect may vary due to several factors. The ACE-inhibiting activity
of the peptides primarily depends on peptide size and amino acid
sequence [34]. As the raw material used for the production of FPHs
was the same, the differences in IC50 are expected to be due to the
enzymes’ different abilities to hydrolyse the raw material into ACE-
inhibiting peptides. These may be due to differences in afﬁnity for
the substrate, enzyme speciﬁcity and differences in optimal
conditions.
Trypsin is a major protease in the enzymatic breakdown of food
protein and contributes to production of peptides with an average
size of 14 amino acids [35], which was conﬁrmed by FPLC analysis
(Fig. 1C). This represents a molecular weight that is within the
reported optimal range for peptides showing high ACE inhibiting
efﬁciency: 2–20 amino acids [36,37]. These small peptides most
likely account for the high ACE-inhibitory activity of Trypsin
hydrolysates. Molecular weight distribution of hydrolysates
produced by Trypsin after 120 min hydrolysis (Fig. 1C) shows that
these hydrolysates had a different peptide molecular weightFig. 5. The IC50 values of FPHs produced by enzymatic hydrolysis using different comproﬁle compared to FPH produced by other enzymes. Hydrolysates
after Corolase PP hydrolysis also contained peptides with a similar
molecular weight as the hydrolysates from Trypsin hydrolysis,
however, ACE-inhibiting activity was lower compared to Trypsin
hydrolysates. It is known that Trypsin exclusively cleaves peptide
chains at the carboxyl side of arginine or lysine [38], which
inﬂuences the molecular weight and terminal sequences of the
produced peptides. Speciﬁcally, Trypsin hydrolysates showed
peaks which represent peptides in the range up to 1200 Da.
Corolase PP seems to produce similar size peptides. In comparison
to the Trypsin hydrolysates, Corolase PP hydrolysates contained
higher amount of free amino acids: 170 mg/g FPH (Corolase PP)
compared to 132 mg/g FPH (Trypsin), which do not show ACE-
inhibiting effects. In addition to the different composition of
peptides, this could also be a reason for the lower ACE – inhibitory
effects of Corolase PP hydrolysates compared to Trypsin hydro-
lysates.
Most proteases used for enzymatic hydrolysis work as
endopeptidases by cleaving peptide bonds within the protein
and generate peptides of various sizes. All enzymes, expect Trypsin
and Seabzyme, produced FPHs with similar ACE-inhibiting activity.
All FPHs contain larger peptides as well as peptides in the range ofmercial enzymes as indicated in the horizontal axis. Hydrolysis time: 120 min.
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inhibition [39]. Several peptides contribute to the ACE inhibition,
but to a different extent. Thus, the overall inhibitory effect of the
FPH depends on the relative proportion of active peptides. All the
studied enzymes are commercial mixtures and contain several
proteases, and are expected to cleave a wide variety of peptide
bonds. Even if the FPHs have similar IC50 values, the constituent
peptides are not necessarily the same.
Seabzyme had the lowest IC50 value after 120 min hydrolysis
(9.5 mg FPH/mL). This difference may be due to larger peptides
with higher molecular weights and absence of C-terminal
sequences ﬁt for inhibition of ACE. The molecular weight
distribution proﬁle of hydrolysate produced with Seabzyme
(Fig. 1C) indicates that this hydrolysate contains a large amount
of larger peptides and lower amounts of small peptides in the range
of 2–20 amino acids, which could explain the low ACE inhibitory
effect. The Bromelain + Papain hydrolysate has a much stronger
ACE inhibitory effect than the Seabzyme hydrolysate. Compared to
the Bromelain + Papain hydrolysate the Seabzyme hydrolysate has
a molecular weight distribution that is slightly shifted towards
larger peptides (to the left). FPH produced with both enzymes had
the lowest degree of hydrolysis (Table 4). These results indicate
that the hydrolysate contained higher amount of larger peptides
and this could play an important role for the lower ACE inhibitory
activity.
3.5.2. Effect of hydrolysis time
The FPHs obtained before addition of commercial enzymes
(stick water, or, point 0) did not show any ACE inhibiting effect.
These hydrolysates are called stick water fractions since the
proteins have not been exposed to hydrolysis by commercial
enzymes. The process of heating the raw material (0 C) and water
mixture to 50 C takes around 30 min. The endogenous enzymes
present in the raw material are active during this period and can
therefore act on the proteins, but they do not seem to cleave the
protein into peptides with ACE-inhibitory activities. The molecular
weight distribution of stick water is shown in Fig. 1B: point 0. The
characteristic feature of this molecular weight distribution is
several peaks in the chromatogram representing relatively small
peptides with molecular weight smaller than 1000 Da (Fig. 1).
These peaks are also found in all 120 min hydrolysates. Since the
stick water does not show any ACE-inhibiting activity and all the
120 min FPHs do, this commonly shared mixture of peptides
cannot explain the ACE-inhibiting effect of the 120 FPHs.
Hydrolysis for 20, 40, 60 and 120 min yielded hydrolysates
which all showed ACE-inhibiting effects in vitro. For hydrolysates
obtained with Protamex and a mixture of Bromelain + Papain, theFig. 6. The IC50 values of FPHs produced by enzymatic hydrolysis using different comme
a function of hydrolysis time. Ala-Tyr st. and Val-Try st. – standards used as controls.largest ACE-inhibiting effect was observed after 120 mins hydro-
lysis, whereas hydrolysis from 60 min till 120 min did not
signiﬁcantly affect the IC50 value. Conversely, for Trypsin the
IC50 value for hydrolysate after 120 min was signiﬁcantly lower
than after 60 min (Fig. 6).
3.6. Inhibition of radiolabelled glucose uptake into CaCo-2E enterocyte
monolayers
The ability of FPH to reduce cellular glucose uptake was
determined in a cell model of human enterocytes. Signiﬁcant
reduction of radiolabelled glucose uptake into CaCo-2E cell
monolayers was observed in presence of the hydrolysate treated
for 20-min with Bromelain + Papain (BrP 20). Compared to
inhibitor-free uptake, 4 mg/mL of BrP 20 reduced the intracellular
glucose accumulation by 32% (Fig. 7; p < 0.05). Hydrolysates from
longer Bromelain + Papain treatments (BrP 60, BrP 120) showed
similar glucose uptake reductions, but the inhibitions were not
statistically signiﬁcant. Hydrolysates produced by other enzymes
did not show signiﬁcant inhibition (Fig. 7). Dose escalation with
the Bromelain + Papain hydrolysates proved their effectiveness
compared to Trypsin hydrolysates or inhibitor-free uptake (Fig. 8).
The BrP 120 showed concentration dependent reduction of
radiolabelled glucose accumulation, where the maximum reduc-
tion of 39% was observed at 8 mg/mL concentration (Fig. 8). Protein
hydrolysates from marine and plant sources have previously been
reported to cause antidiabetic effects through inhibition of
intestinal digestive enzymes such as a-amylase [40], or inhibition
of apoptosis in pancreatic cells [41]. The present study expands the
concept that dietary bioactive compounds can blunt blood sugar
peaks by inhibiting intestinal glucose absorption [42]. The CaCo-2E
cells used in this study highly express both of the main intestinal
glucose transporter types, SGLTs and GLUTs, which are inhibited by
certain phenolics [43,44]. Similar to phenolics, speciﬁc peptides in
the FPH might be hydrophobic in nature to bind the glucose
transporter proteins and cause a non-competitive inhibition. The
exact mechanism and kinetics remain to be determined in future
experiments. The investigated FPH concentrations of 1–8 mg/mL
reﬂect the realistic concentration of peptides in the small intestine
[45], providing the rationale for further studies of FPH in vivo.
Hydrolysates which were found to possess signiﬁcant glucose
transport inhibiting activity were derived from Bromelain + Papain
hydrolysis. Distinct peptide proﬁle produced by the cysteine
endoproteases Bromelain and Papain in comparison to the serine
endoproteases Trypsin, Protamex, Protex and Corolase 7089 likely
explains the different inhibitory activities of the hydrolysates.
During Bromelain + Papain hydrolysis the relative proportion ofrcial enzymes (Trypsin (T), mixture of Bromelain + Papain (BrP) and Protamex (P)) as
Fig. 7. Effect of FPHs on glucose uptake into CaCo-2E cells. 100% glucose uptake (+) was determined in absence of FPHs. Hydrolysis with: Protamex (Pr 60), Protamex without
addition of water (Pr-W 60), Seabzyme (Sz 60), Protex 6L (P-6L 60), Corolase 7089 (C-7089 60), Trypsin (T 60) and Corolase PP (C-PP 60) for 60 min, and Bromelain + Papain for
0 min (BrP 0), 20 min (BrP 20), 60 min (BrP 60) and 120 min (BrP 120). Error bars represent standard deviations of 2–9 independent experiments, each consisting of 2–
3 replicates (N = 5-26). Statistical signiﬁcance (p < 0.05) is indicated as “*”.
Fig. 8. Effect of Bromelain + Papain and Trypsin hydrolysate concentration on glucose uptake into CaCo-2E cells. 100% glucose uptake (+) was determined in absence of FPH.
Hydrolysis with: Bromelain + Papain for 0 min (BrP 0), 60 min (BrP 60) and 120 min (BrP 120), and Trypsin for 60 min (T 60). Error bars represent standard deviations of 2–9
experiments, each consisting of 2–3 replicates (N = 5-26). Statistical signiﬁcance (p < 0.05) is indicated as “*”.
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proportion of other peptides decreased (Fig. 1A), suggesting that
these dipeptides could have a role in the regulation of glucose
uptake. 300 Da dipeptides were also found in the other hydro-
lysates (Fig. 1C) but their amino acid composition, which most
probably determines the inhibitory activity, was expected to vary
depending on the enzyme used.
4. Conclusions
The hydrolysis of thermally defatted salmon backbones yielded
ﬁsh protein hydrolysates with bioactive properties. All studied FPH
showed potential antioxidative properties in the form of DPPH and
iron chelating ability. As opposed to the DPPH scavenging ability,
intact proteins and larger peptides appeared to have better ability
to chelate iron than smaller peptides. FPH also showed ACE-
inhibiting effect in vitro. The ACE-inhibiting activity depended on
the commercial enzyme used and time of hydrolysis, which
determined the peptide sequence and molecular weight. 120-min
hydrolysis with Trypsin generated FPH with the highest ACE-
inhibiting activity (IC50 = 0.92 mg FPH/mL), which was most
probably related to a high content of <1200 Da peptides in this
hydrolysate. FPH obtained after hydrolysis with Bromelain + Papa-
in showed inhibitory effects on cellular glucose transport, with
max. 39% reduction of glucose uptake into intestinal CaCo-2E cells.
Fish protein hydrolysates obtained by Trypsin, Bromelain + Papainand Protamex treatment showed the highest ACE inhibitory, GLUT/
SGLT inhibitory and in vitro antioxidative activities, respectively.
Correlation was observed in the measured bioactivities, degree of
hydrolysis and molecular weight proﬁles, supporting prolonged
hydrolysis of at least 120 min for increased DPPH radical
scavenging and ACE-inhibiting activity.
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